Last edition
News about "Sandoz CEO Richard Saynor"
Sandoz, a global leader in generics and biosimilars, has signed a non-binding term sheet to acquire Evotec SE’s Just-Evotec Biologics EU SAS, including the state-of-the-art J.POD biologics development and manufacturing facility in Toulouse, France.
Sandoz CEO Richard Saynor | 06/08/2025 | By Darshana | 430
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members